126
Views
1
CrossRef citations to date
0
Altmetric
Hemoglobinopathy

First report of a nonsense mutation at codon 15(TGG→TAG) in exon 1 of the β globin gene in a β thalassemia trait in State of Orissa, India

, &
Pages 65-67 | Published online: 29 Nov 2013

References

  • Fucharoen S, Winichagoon P. Thalassaemia in South east Asia: problems and strategies for prevention and control. Southeast Asian J Trop Med Public Health.1992; 23: 647–655.
  • Agarwal S, Pradhan M,Gupta UR, Sarwai S, Agarwal SS.Geographic and ethnic distribution of beta thalasaemia muta-tions in Utter pradesh,India.Haemog/obin 2000; 24(2): 89–97.
  • Orkin SH, Kazazian Jr. HH. The mutation and polymorphism ofthe human beta globin gene and its surrounding DNA. Annu Rev Genet 1984; 18: 131–171.
  • Chhotray GP, Dash BP, Ranjit MR. Spectrum of hemoglobino-pathies in Orissa. Hemoglobin 2004; 28(2): 117–122.
  • Dacie INT, Lewin SM. Practical haematology, 8th edition. Edinburgh: Churchill Livingstone, 1995.
  • Zhang D, Okada S, Kawabata T, Yasuda T. An improved simple colorimetric method for quantification of non tranferrin bound iron in serum. Biochem Mol Biol Int 1995; 35: 635.
  • Cai SP,Wall J, Kan YAW, Chehab FF. Reverse dot blot probe for the screening of β-thalassaemia mutations in Asian and American Blacks. Hum Mutant. 1994; 3(1): 59–63.
  • Baysal E, Huisman THJ. Detection of common deletional alphathalassaemia-2 determinants by PCR. Am J Hematol 1994; 46: 208–213.
  • Smetanina NS, Huisman TH. Detection of alpha thalasaemia-2(-3·kb) and its corresponding triplication ααα(anti 3·7kb) by PCR: an improved technical change. Am J Hemato11996; 53(2): 202–203.
  • Cazolla M, Beguin Y, Bergamachi G, Guarnone R, Cerani P. Soluble transferring receptor as: a potential determinant of iron loading in congenital anemias due to ineffective erythropoiesis. Br J Haematol 1999; 106: 752–755.
  • Aldouri MA, Wonke B, Hoffbrand AV, Flynn DM, Laulicht M, Fenton LA, et al. Iron state and hepatic disease in patients with thalasaemia major treated with long term subcutaneous deferriox-amine. J Clin Pathol 1987; 40:1353–1359.
  • Prati D, Zanella A, Farma E, De Mattei C, Basoni P, Zappa M, et al. A multicentre prospective study on the risk of acquiring liver disease in anti-hepatitis C virus negative patient affected from homozygous beta thalasaemia. Blood 1998; 92(9): 3460–3464.
  • Galanello R, Barella S, Turco PM, Giangu N, Cao A, Dore F, et.al. Serum erythropoietin in high and low fetal hemoglobin beta thlassaemia intermedia patients. Blood 1994; 83(2): 561–565.
  • Senanayake MP, Suraweera SA, Hubert HD. Thyroid function in thalasaemia major. Ceylon Med J 1999; 44(4): 166168.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.